Hospital Systems Accuse Becton, Dickinson and Company of Monopolizing the Safety Syring and IV Markets
A Georgia hospital system last week sued Becton Dickinson & Co. (NYSE:BDX) for allegedly seeking to monopolize the safety syringe and IV markets, seeking class-action status for acute care hospitals that bought the BD devices.
“Monopolist Becton, Dickinson and Company has systematically subverted innovation and competition for the sale of hypodermic syringes and IV catheters to United States hospitals (‘acute care providers’) for over a half century and monopolized the relevant markets in which they are sold,” the July 17 lawsuit alleges.
Help employers find you! Check out all the jobs and post your resume.
“Monopolist Becton, Dickinson and Company has systematically subverted innovation and competition for the sale of hypodermic syringes and IV catheters to United States hospitals (‘acute care providers’) for over a half century and monopolized the relevant markets in which they are sold,” the July 17 lawsuit alleges.
Help employers find you! Check out all the jobs and post your resume.